Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-05-10. Part of the stroke caregiver research overview.
Short answer. The "my parent isn't the same person" experience after stroke usually comes from two overlapping but distinct sources: post-stroke depression (PSD), which is highly prevalent and treatable, and injury-driven changes in emotional regulation, initiation, and social processing, which are caused by the lesion itself. Robinson's foundational work (Robinson, 2003) and Hackett's systematic reviews (Hackett et al., 2005) describe PSD as affecting roughly one in three survivors. The 2016 AHA/ASA guidelines (Winstein et al., 2016) recommend screening at every follow-up, because PSD is under-diagnosed and predicts worse rehabilitation engagement and survival. The injury-driven changes are separate, often coexist with PSD, and respond to different interventions.
Hackett and colleagues' systematic review (Hackett et al., 2005) pooled data across multiple cohorts and estimated PSD prevalence at roughly 33% at any time post-stroke, with peaks in the first 3–6 months. Robinson's neurobiological work (Robinson, 2003) describes PSD as a syndrome with both reactive (psychological adjustment to the stroke) and biological (lesion-related disruption of mood circuits) components. The implication is that PSD is not "understandable sadness" — it is a clinical entity with measurable effects on outcome.
PSD predicts:
The 2016 AHA/ASA guidelines (Winstein et al., 2016) make explicit, evidence-graded recommendations: screen for PSD with a validated instrument (PHQ-9, Hospital Anxiety and Depression Scale, or equivalent) at hospital discharge and at every subsequent follow-up; treat PSD with SSRIs and/or structured psychotherapy when identified.
Separate from PSD, stroke can directly alter:
These are injury effects, not character changes. They are shaped by lesion location, fatigue, medication, and cognitive load. Many improve substantially over the first 6–12 months, though some persist.
| Feature | Post-stroke depression | Apathy (lesion-driven) | Pseudobulbar affect | Fatigue |
|---|---|---|---|---|
| Internal mood | Sad, low, hopeless | Neutral or flat | Often neutral | Often neutral |
| Reported interest | Reduced | Preserved when prompted | Preserved | Reduced |
| Engages when prompted | Resistance | Usually yes | Yes | Variable |
| Crying | Matches mood | Rare | Mismatched, sudden | Rare |
| Self-blame | Common | Absent | Absent | Absent |
| Sleep | Disrupted | Often normal | Normal | Excessive |
| Response to SSRIs | Often good | Limited | Often good (dextromethorphan/quinidine more specific) | Limited |
The distinction matters because the treatments are different. SSRIs and structured psychotherapy are first-line for PSD. Apathy may respond to dopaminergic agents or to behavioural activation but not to the same antidepressant pathways. Pseudobulbar affect has a specific pharmacological treatment. Fatigue requires energy management and screening for sleep apnoea, anaemia, and thyroid problems.
1. Get screening. Ask the rehab team or primary care provider for a PHQ-9 at every visit. If they don't offer one, request it. The instrument takes two minutes and has strong evidence in stroke populations. 2. Note what the survivor actually says about themselves. "I feel useless" is depression. "I just don't feel like starting anything" without sadness is more likely apathy. "I can't stop crying but I'm not sad" is more likely pseudobulbar affect. 3. Track behavioural markers separately. Engagement with rehab. Conversation initiation. Interest in previously enjoyed activities. Sleep quality. Each is a different signal. 4. Treat what is treatable. The research consensus across cohorts (Robinson, Hackett, AHA/ASA) is that PSD is under-treated. SSRIs in post-stroke populations have a generally favourable safety profile and meaningful effect on mood and rehabilitation engagement. 5. Reframe injury-driven changes. Lability, apathy, and reduced empathic accuracy are not the survivor "becoming someone else." They are localised injury effects. Reframing this with the survivor and with other family members reduces blame and improves the relational climate. 6. Watch for caregiver depression. Caregivers of stroke survivors have elevated rates of depression themselves (see the separate article on caregiver burnout). Caregiver depression is a known confounder in survivor assessments.
---
Unseen Progress publishes long-form caregiver research and builds research-backed daily trackers for the families covered. See the full stroke caregiver research overview for the complete framework.